Study description
A prospective, observational, monocentric, study to evaluate the use of Cureety in older patients compared to younger patients.
Key results
Older patients (70+) were as compliant as younger ones (mean 66%, no group difference p=0.29)Older patients divided in 2 groups based on the 1st month of monitoring: 'Tolerant' (79%) and 'Non-tolerant' (21%)Progression-free survival was significantly better in 'Tolerant' patients (64.6% vs 23.4%, p=0.034)
Publication
Rivère et al., 2022, Int. J. Cancer
